Lipirose 10 Tablet contains Rosuvastatin 10 mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, thereby decreasing hepatic cholesterol production and upregulating LDL receptors, which enhances clearance of LDL from the bloodstream. Lipirose 10 is prescribed as an adjunct to diet and lifestyle modifications, including exercise and weight control, to reduce the risk of cardiovascular events such as myocardial infarction, stroke, and the need for revascularization procedures in patients with established coronary artery disease or multiple risk factors. The recommended dosage should be individualized based on patient response and tolerability, with regular monitoring of lipid levels and liver function tests advised. Caution is warranted in patients with hepatic impairment, renal dysfunction, or a history of muscle disorders. Lipirose 10 should be used under medical supervision to optimize therapeutic outcomes and minimize potential adverse effects.